Lilly Breast Cancer Drug Results May Challenge Pfizer Pill 1:24 PM health No comments Lilly Breast Cancer Drug Results May Challenge Pfizer Pill Bloomberg UPDATE 1-Lilly takes on Pfizer, Novartis with new breast cancer drug data Reuters ESMO 2017: Lilly's MONARCH 3 and RANGE phase III readouts for advanced breast and urothelial cancers BioWorld Online #ESMO17: Eli Lilly sets the stage for a CDK 4/6 showdown with Pfizer, Novartis — but not exactly to its advantage Endpoints NewsFull coverage Share It Facebook Twitter LinkedIn BLOG AUTHOR Please add Follow him @ Linkedin | Instagram | Twitter
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.